Crinetics Announces Positive Topline Results from Phase 2 Trial of Paltusotine for the Treatment of Carcinoid Syndrome tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
SAN DIEGO, March 11, 2024 (GLOBE NEWSWIRE) Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on March 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted non-qualified
Citigroup assumed coverage on shares of Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) in a research note published on Wednesday morning, MarketBeat Ratings reports. The firm issued a buy rating and a $68.00 price objective on the stock. Several other equities research analysts also recently weighed in on CRNX. Oppenheimer increased their price target on Crinetics […]
Crinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report) had its price objective lifted by research analysts at Oppenheimer from $46.00 to $48.00 in a research note issued on Thursday, Benzinga reports. The firm currently has an “outperform” rating on the stock. Oppenheimer’s price target would indicate a potential upside of 7.50% from the stock’s previous close. […]
Crinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.90) earnings per share for the quarter, missing the consensus estimate of ($0.89) by ($0.01), Briefing.com reports. Crinetics Pharmaceuticals had a negative net margin of 4,223.27% and a negative return on equity of 57.04%. The business’s revenue for […]